First‐line epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitor alone or with whole‐brain radiotherapy for brain metastases in patients with EGFR …
Y Chen, J Yang, X Li, D Hao, X Wu, Y Yang… - Cancer …, 2016 - Wiley Online Library
We proposed to compare the outcomes of first‐line epidermal growth factor receptor–
tyrosine kinase inhibitor (EGFR‐TKI) alone with EGFR‐TKI plus whole‐brain radiotherapy …
tyrosine kinase inhibitor (EGFR‐TKI) alone with EGFR‐TKI plus whole‐brain radiotherapy …
[PDF][PDF] First-line epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitor alone or with whole-brain radiotherapy for brain metastases in patients with EGFR …
Y Chen, J Yang, X Li, D Hao, X Wu, Y Yang, C He… - Cancer Sci, 2016 - cyberleninka.org
Results Baseline characteristics of patients. From September 1, 2008, to September 1, 2014,
we screened 1665 patients with stage IV lung adenocarcinoma and 132 met the eligibility …
we screened 1665 patients with stage IV lung adenocarcinoma and 132 met the eligibility …
[引用][C] First‐line epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitor alone or with whole‐brain radiotherapy for brain metastases in patients with EGFR …
Y Chen, J Yang, X Li, D Hao, X Wu, Y Yang, C He… - Cancer Science, 2016 - cir.nii.ac.jp
First‐line epidermal growth factor receptor ( EGFR )–tyrosine kinase inhibitor alone or with
whole‐brain radiotherapy for brain metastases in patients with EGFR ‐mutated lung …
whole‐brain radiotherapy for brain metastases in patients with EGFR ‐mutated lung …
[HTML][HTML] First‐line epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitor alone or with whole‐brain radiotherapy for brain metastases in patients with …
Y Chen, J Yang, X Li, D Hao, X Wu, Y Yang, C He… - Cancer …, 2016 - ncbi.nlm.nih.gov
We proposed to compare the outcomes of first‐line epidermal growth factor receptor–
tyrosine kinase inhibitor (EGFR‐TKI) alone with EGFR‐TKI plus whole‐brain radiotherapy …
tyrosine kinase inhibitor (EGFR‐TKI) alone with EGFR‐TKI plus whole‐brain radiotherapy …
First-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor alone or with whole-brain radiotherapy for brain metastases in patients with EGFR-mutated …
Y Chen, J Yang, X Li, D Hao, X Wu, Y Yang… - Cancer …, 2016 - pubmed.ncbi.nlm.nih.gov
We proposed to compare the outcomes of first-line epidermal growth factor receptor-tyrosine
kinase inhibitor (EGFR-TKI) alone with EGFR-TKI plus whole-brain radiotherapy (WBRT) for …
kinase inhibitor (EGFR-TKI) alone with EGFR-TKI plus whole-brain radiotherapy (WBRT) for …
First-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor alone or with whole-brain radiotherapy for brain metastases in patients with EGFR-mutated …
Y Chen, J Yang, X Li, D Hao, X Wu, Y Yang, C He… - Cancer …, 2016 - europepmc.org
We proposed to compare the outcomes of first‐line epidermal growth factor receptor–
tyrosine kinase inhibitor (EGFR‐TKI) alone with EGFR‐TKI plus whole‐brain radiotherapy …
tyrosine kinase inhibitor (EGFR‐TKI) alone with EGFR‐TKI plus whole‐brain radiotherapy …
First‐line epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitor alone or with whole‐brain radiotherapy for brain metastases in patients with EGFR …
Y Chen, J Yang, X Li, D Hao, X Wu, Y Yang… - Cancer …, 2016 - search.proquest.com
We proposed to compare the outcomes of first‐line epidermal growth factor receptor–
tyrosine kinase inhibitor (EGFR‐TKI) alone with EGFR‐TKI plus whole‐brain radiotherapy …
tyrosine kinase inhibitor (EGFR‐TKI) alone with EGFR‐TKI plus whole‐brain radiotherapy …
First-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor alone or with whole-brain radiotherapy for brain metastases in patients with EGFR-mutated …
Y Chen, J Yang, X Li, D Hao, X Wu, Y Yang, C He… - Cancer …, 2016 - europepmc.org
We proposed to compare the outcomes of first‐line epidermal growth factor receptor–
tyrosine kinase inhibitor (EGFR‐TKI) alone with EGFR‐TKI plus whole‐brain radiotherapy …
tyrosine kinase inhibitor (EGFR‐TKI) alone with EGFR‐TKI plus whole‐brain radiotherapy …